OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2018
(3)
2022
(2)
2016
(2)
2025
(1)
2024
(1)
2021
(1)
2019
(1)
2012
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
Not available
S-EPMC6397541
|
biostudies-literature
Cite
Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.
Not available
S-EPMC3603366
|
biostudies-literature
Cite
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.
Not available
S-EPMC6276789
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Not available
S-EPMC6193457
|
biostudies-literature
Cite
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Not available
S-EPMC8725568
|
biostudies-literature
Cite
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Not available
S-EPMC4962376
|
biostudies-literature
Cite
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Not available
S-EPMC11797383
|
biostudies-literature
Cite
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.
Not available
S-EPMC5902191
|
biostudies-literature
Cite
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Not available
S-EPMC4630206
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets